Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice

BACKGROUND: Mesenchymal stem cell (MSC) transplantation has emerged as a promising therapy for liver fibrosis. Issues concerning poor MSC survival and engraftment in the fibrotic liver still persist and warrant development of a strategy to increase MSC potency for liver repair. The present study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasir, Ghazanfar Ali, Mohsin, Sadia, Khan, Mohsin, Shams, Sulaiman, Ali, Gibran, Khan, Shaheen N, Riazuddin, Sheikh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636128/
https://www.ncbi.nlm.nih.gov/pubmed/23531302
http://dx.doi.org/10.1186/1479-5876-11-78

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636128/
https://www.ncbi.nlm.nih.gov/pubmed/23531302
http://dx.doi.org/10.1186/1479-5876-11-78

Ejemplares similares